These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35657581)
1. An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton's Tyrosine Kinase Inhibitor. Cheng Y; Liu L; Xue Y; Zhou S; Li Y Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):579-592. PubMed ID: 35657581 [TBL] [Abstract][Full Text] [Related]
2. An open-label, phase 1, randomized, three treatments, three-period, crossover, relative bioavailability study of CC-292, a potent and orally available inhibitor of bruton tyrosine kinase. Cheng Y; Liu L; Xue Y; Zhou S; Li Y J Clin Pharm Ther; 2022 Aug; 47(8):1186-1193. PubMed ID: 35307850 [TBL] [Abstract][Full Text] [Related]
3. Results From Phase I Studies Investigating the Dose Linearity of Finerenone Tablets and the Influence of Food or pH-Modifying Comedications on its Pharmacokinetics in Healthy Male Volunteers. Heinig R; Nagelschmitz J; Loewen S Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):549-559. PubMed ID: 35612708 [TBL] [Abstract][Full Text] [Related]
4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
5. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers. Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418 [TBL] [Abstract][Full Text] [Related]
6. The effect of food on the absorption and pharmacokinetics of rivaroxaban. Stampfuss J; Kubitza D; Becka M; Mueck W Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226 [TBL] [Abstract][Full Text] [Related]
7. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine. Kinzler ER; Pantaleon C; Iverson M; Aigner S Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694 [TBL] [Abstract][Full Text] [Related]
8. The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects. Anderson K; Zheng H; Kotecha M; Cuvin J; Scott B; Sharma S; Qin AR; Namour F; Xin Y Clin Pharmacol Drug Dev; 2019 Jul; 8(5):585-594. PubMed ID: 30768860 [TBL] [Abstract][Full Text] [Related]
9. Single-dose clinical pharmacokinetic studies of gefitinib. Swaisland HC; Smith RP; Laight A; Kerr DJ; Ranson M; Wilder-Smith CH; Duvauchelle T Clin Pharmacokinet; 2005; 44(11):1165-77. PubMed ID: 16231967 [TBL] [Abstract][Full Text] [Related]
10. Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects. Lindsay J; Mudge S; Thompson GR Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297369 [TBL] [Abstract][Full Text] [Related]
11. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects. Disanto AR; Golden G Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Food on Tramadol and Celecoxib Bioavailability Following Oral Administration of Co-Crystal of Tramadol-Celecoxib (CTC): A Randomised, Open-Label, Single-Dose, Crossover Study in Healthy Volunteers. Encina G; Encabo M; Escriche M; Lahjou M; Sicard E; Smith K; Gascon N; Plata-Salamán C; Videla S Clin Drug Investig; 2018 Sep; 38(9):819-827. PubMed ID: 30008052 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Food or Omeprazole on the Pharmacokinetics of Osimertinib in Patients With Non-Small-Cell Lung Cancer and in Healthy Volunteers. Vishwanathan K; Dickinson PA; Bui K; Cassier PA; Greystoke A; Lisbon E; Moreno V; So K; Thomas K; Weilert D; Yap TA; Plummer R J Clin Pharmacol; 2018 Apr; 58(4):474-484. PubMed ID: 29178442 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study. Parikh N; Goskonda V; Chavan A; Dillaha L Clin Drug Investig; 2013 Jun; 33(6):391-400. PubMed ID: 23605506 [TBL] [Abstract][Full Text] [Related]
15. Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520. Verheijen RB; van der Biessen DAJ; Hotte SJ; Siu LL; Spreafico A; de Jonge MJA; Pronk LC; De Vos FYFL; Schnell D; Hirte HW; Steeghs N; Lolkema MP Target Oncol; 2019 Feb; 14(1):67-74. PubMed ID: 30742245 [TBL] [Abstract][Full Text] [Related]
16. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults. Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174 [TBL] [Abstract][Full Text] [Related]
17. Comparative Bioavailability of Metformin Hydrochloride Oral Solution Versus Metformin Hydrochloride Tablets in Fasting Mexican Healthy Volunteers. Garza-Ocañas L; González-Canudas J; Tamez-de la O E; Badillo-Castañeda C; Gómez-Meza MV; Romero-Antonio Y; Molina-Pérez A; Amador-Hernández AG Adv Ther; 2019 Feb; 36(2):407-415. PubMed ID: 30565181 [TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability and food effect of the galectin-3 inhibitor selvigaltin (GB1211) administered as a tablet in healthy participants (GALBA-1). Aslanis V; Abd-Elaziz K; Slack RJ; Brinch A; Gravelle L; Morley W; Phung D; Herman K; Holyer I; Poulsen KK; Dogterom P; Tantawi S; Zetterberg FR; Jacoby B; Schambye H; Lindmark B Cancer Chemother Pharmacol; 2024 Nov; 94(5):707-720. PubMed ID: 39167148 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects. Osterloh IH; Muirhead GJ; Sultana S; Whaley S; van den Berg F; Atiee G J Sex Med; 2018 Nov; 15(11):1547-1557. PubMed ID: 30341006 [TBL] [Abstract][Full Text] [Related]
20. Phase I crossover study of DNA-protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension. Becker A; Krebs-Brown A; Vetter C; Reuter T; Rodriguez-Gutierrez A; You X; Lissy M Clin Transl Sci; 2023 Dec; 16(12):2628-2639. PubMed ID: 37905356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]